Most Recent

image: BeetleCam, Take Two

BeetleCam, Take Two

By | March 15, 2012

The BeetleCam is back! And this time, it’s lion proof. 

0 Comments

image: Electron Microscopy Through the Ages

Electron Microscopy Through the Ages

By | March 1, 2012

Take a tour through the revolutionary menthod's past, present, and future.

8 Comments

image: Cyan Wonders

Cyan Wonders

By | February 1, 2012

In 1842, Anna Atkins, a 43-year-old amateur botanist from Kent, England, began experimenting with a brand-new photographic process called cyanotype or blue-print. 

0 Comments

image: The View From Above

The View From Above

By | February 1, 2012

Satellite imagery is giving biologists a whole new perspective on the phenomena they study.

0 Comments

image: Bat Hunt

Bat Hunt

By | January 1, 2012

Bucknell University mammalogist DeeAnn Reeder raises nets high into the darkened forest canopies of South Sudan to catch bats.

3 Comments

image: Newts' New Eyes

Newts' New Eyes

By | December 1, 2011

Cut off a newt’s tail or a leg, or remove a lens from its eye, and it grows back. However, whether newts can continue to do this throughout their lives, or lose the ability as they get older, has remained a mystery. 

3 Comments

Saving Rwanda's Gorillas

By | October 1, 2011

In late June 2009, a small group of mountain gorillas in Rwanda’s Volcanoes National Park began to fall ill. One by one, 11 of the dozen apes started exhibiting severe respiratory problems. 

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech